Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery - Mehta, JL; Chen, L; Nichols, WW (J Cardiovasc Pharmacol, 1998)
et al.